Panova Ina G, Tatikolov Alexander S
International Scientific and Practical Center of Tissue Proliferation, 29/14 Prechistenka Str., 119034 Moscow, Russia.
N.M. Emanuel Institute of Biochemical Physics, Russian Academy of Sciences, 4 Kosygin Str., 119334 Moscow, Russia.
Pharmaceuticals (Basel). 2023 Jul 28;16(8):1077. doi: 10.3390/ph16081077.
The use of conventional contrast media for diagnostic purposes (in particular, Gd-containing and iodinated agents) causes a large number of complications, the most common of which is contrast-induced nephropathy. It has been shown that after exposure to contrast agents, oxidative stress often occurs in patients, especially in people suffering from various diseases. Antioxidants in the human body can diminish the pathological consequences of the use of contrast media by suppressing oxidative stress. This review considers the research studies on the role of antioxidants in preventing the negative consequences of the use of contrast agents in diagnostics (mainly contrast-induced nephropathy) and the clinical trials of different antioxidant drugs against contrast-induced nephropathy. Composite antioxidant/contrast systems as theranostic agents are also considered.
用于诊断目的的传统造影剂(特别是含钆剂和碘剂)会引发大量并发症,其中最常见的是造影剂肾病。研究表明,接触造影剂后,患者体内常发生氧化应激,尤其是患有各种疾病的人群。人体中的抗氧化剂可通过抑制氧化应激来减轻使用造影剂的病理后果。本文综述了关于抗氧化剂在预防诊断中使用造影剂的负面后果(主要是造影剂肾病)方面的研究,以及不同抗氧化剂药物针对造影剂肾病的临床试验。还探讨了复合抗氧化剂/造影剂系统作为诊疗试剂的情况。